Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,052 | 101,211 | 67,602 | 45,157 | 291,064 |
| Marketable Securities | 205,304 | 318,787 | 284,367 | 143,555 | N/A |
| Receivables | 1,177 | 3,680 | 5,878 | N/A | N/A |
| TOTAL | $306,252 | $440,039 | $369,771 | $209,875 | $298,700 |
| Non-Current Assets | |||||
| PPE Net | 7,313 | 10,928 | 11,191 | 7,681 | 6,261 |
| Other Non-Current Assets | 63,813 | 75,354 | 88,230 | 34,500 | 872 |
| TOTAL | $71,126 | $86,282 | $99,421 | $42,181 | $7,133 |
| Total Assets | $377,378 | $526,321 | $469,192 | $252,056 | $305,833 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,289 | 4,259 | 3,277 | 5,990 | 706 |
| Accrued Expenses | 17,682 | 13,343 | 11,325 | 7,576 | 6,013 |
| TOTAL | $24,451 | $39,482 | $158,796 | $21,972 | $6,719 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 342 | 13,654 | 132,261 | 0 | N/A |
| Other Non-Current Liabilities | 46,794 | 51,648 | 60,321 | 17,530 | 396 |
| TOTAL | $46,794 | $58,161 | $68,036 | $17,530 | $396 |
| Total Liabilities | $71,245 | $97,643 | $226,832 | $39,502 | $7,115 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,284 | 37,595 | 33,601 | 33,076 | 31,251 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -273,094 | -129,344 | -194,970 | -188,285 | -93,669 |
| Other shareholders' equity | 652 | -43 | 195 | -2,057 | 0 |
| TOTAL | $306,133 | $428,678 | $242,360 | $212,554 | $298,718 |
| Total Liabilities And Equity | $377,378 | $526,321 | $469,192 | $252,056 | $305,833 |